Aug 2026· Applied microbiology· 0 citations· 75 references
TL;DR
This review examines farnesol across pathogenic and non-pathogenic fungi, emphasizing its roles in morphogenesis, biofilm development, stress adaptation, membrane-associated physiology, and ecological interaction.
Abstract
Farnesol is a small isoprenoid metabolite that has emerged as a key regulator of fungal biology beyond its original identification as a quorum-sensing molecule in Candida albicans. This review examines farnesol across pathogenic and non-pathogenic fungi, emphasizing its roles in morphogenesis, biofilm development, stress adaptation, membrane-associated physiology, and ecological interaction. In pathogenic fungi, farnesol modulates virulence-related traits, antifungal susceptibility, and host interaction, while in non-pathogenic systems, it influences growth, differentiation, and metabolic balance. Evidence from Saccharomyces cerevisiae, Trichoderma, Candidozyma auris (formerly known as Candida auris), and other fungi highlights the context-dependent nature of its effects. We also discuss farnesol biosynthesis, secretion, and the apparent absence of canonical salvage pathways in fungi. Together, these findings support a broader view of farnesol as a multifunctional fungal metabolite that links signaling with metabolism. Understanding its diverse biological roles may clarify fungal evolution and inform future strategies targeting fungal persistence, adaptation, and antifungal tolerance.
The global emergence of multidrug-resistant fungal pathogens, including Candida auris, Candida albicans, Aspergillus fumigatus, Cryptococcus neoformans, and Pneumocystis jirovecii, poses a growing threat to public health, particularly among immunocompromised individuals. The limited number of available antifungal drug...
C. Achilonu· Drugs and Drug Candidates· 0 citations
The more the authors learn about S. schoenii’s contact-dependent attack, the greater the opportunities to deploy S. schoenii as a safe, mycotoxin-free biocontrol agent against both multi-drug-resistant Candida auris and post-harvest Penicillium molds.
Divya Kriti, Marjan Barazandeh, J. U. Ogbede et al.· Journal of Fungi· 0 citations
This review reframes MHB not as generic growth promoters, but as stage-specific regulators of the fungal development program, integrating current evidence on transcriptional responses, metabolite-mediated signaling, and emerging small RNA regulatory networks across five sequential phases of the fungal life cycle.
A. Pennesi, Antonietta Mello, M. Acquaviva et al.· Frontiers in Plant Science· 0 citations
The alarming rise of antibiotic-resistant bacteria has emerged as a major global health concern, intensifying the urgent need for novel bioactive compounds from natural sources. In recent years, scientific interest in endophytic fungi, which reside asymptomatically within plant tissues, has grown substantially. These m...
Anjitha Suman, S. Sugathan· Trends in Current Biology· 0 citations
This narrative-critical review integrates ecological factors influencing endophytic diversity with advanced strategies to awaken cryptic biosynthetic pathways and critically analyzes pharmacological metrics, specifically minimum inhibitory concentration, cytotoxicity, Selectivity Index, and the potential of fungal meta...
Inherni Marti Abna, M. S. Wibowo, I. Fidrianny et al.· Sains Malaysiana· 0 citations
Candidozyma auris (formerly Candida auris) is a globally emerging, multidrug-resistant fungal pathogen characterized by its unique ability to colonize human skin and persist on abiotic surfaces. Central to its survival and pathogenicity is the fungal cell wall, a highly dynamic structure that mediates host-pathogen int...
Apoorva Soni, Romana Madelová, L. Paulovičová et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.